zepbound glp-1 receptor agonist hydration effects 2025 Weight Loss Drugs: How Semaglutide & Tirzepatide Redefine Obesity Care Rybelsus Dosing Update & Single
Description
The following variables were included in a logistic regression model used to estimate propensity scores (PS): age, gender, pre-existing cardiovascular disease (coronary heart disease, stroke, transient ischemic attack, acute myocardial infarction, peripheral vascular disease) and heart failure

BMJ , 366 , l5003

Tschop M, Noguieras R, Ahren B

SELECT CVOT trial investigated the cardiovascular safety of semaglutide 2.4 mg therapy once a week in a group of 17,605 overweight or obese adults over the age of 45 with no history of T2DM

Bisaga, A., Danysz, W

Key Effects: Mimicking Incretin Hormones Functions like endogenous GLP-1 to regulate metabolism and appetite
